Beta-thalassemias are blood disorders characterized by poorly understood clinical phenotypes ranging from asymptomatic to severe anemia. Metabolic composition of the human placenta could be affected by the presence of pathological states such as β-thalassemia. The aim of our study was to describe metabolic changes in chorionic villi samples of fetuses affected by β-thalassemia compared to a control group by applying a metabolomics approach
IntroductionPre-eclampsia is a hypertensive gestational disorder that affects approximately 5% of al...
β-thalassemia is one of the most common monogenic disorders and a life-threatening health issue in c...
Introduction Metabolomics identifies phenotypical groups with specific metabolic profiles, being inc...
Beta-thalassemias are blood disorders characterized by poorly understood clinical phenotypes ranging...
Placenta-related biological samples are used in biomedical research to investigate placental develop...
Background: The etiology of preeclampsia (PE) remains unclear. With the utilization of metabolomics,...
Background: The etiology of preeclampsia (PE) remains unclear. With the utilization of metabolomics,...
Metabolomics in maternal-fetal medicine is still an "embryonic" science. However, there is already a...
Background: The etiology of preeclampsia (PE) remains unclear. With the utilization of metabolomics,...
Fetal growth may be impaired by poor placental function or maternal conditions, each of which can in...
Background: The etiology of preeclampsia (PE) remains unclear. With the utilization of metabolomics,...
Background: The etiology of preeclampsia (PE) remains unclear. With the utilization of metabolomics,...
Introduction Preeclampsia is a heterogeneous gestational disease characterized by maternal hypertens...
Background: To study the effectiveness of choronic villous sampling, followed by molecular analysis,...
Background: Chronic venous disease (CVD) is a prevalent lower limb venous pathology that especially ...
IntroductionPre-eclampsia is a hypertensive gestational disorder that affects approximately 5% of al...
β-thalassemia is one of the most common monogenic disorders and a life-threatening health issue in c...
Introduction Metabolomics identifies phenotypical groups with specific metabolic profiles, being inc...
Beta-thalassemias are blood disorders characterized by poorly understood clinical phenotypes ranging...
Placenta-related biological samples are used in biomedical research to investigate placental develop...
Background: The etiology of preeclampsia (PE) remains unclear. With the utilization of metabolomics,...
Background: The etiology of preeclampsia (PE) remains unclear. With the utilization of metabolomics,...
Metabolomics in maternal-fetal medicine is still an "embryonic" science. However, there is already a...
Background: The etiology of preeclampsia (PE) remains unclear. With the utilization of metabolomics,...
Fetal growth may be impaired by poor placental function or maternal conditions, each of which can in...
Background: The etiology of preeclampsia (PE) remains unclear. With the utilization of metabolomics,...
Background: The etiology of preeclampsia (PE) remains unclear. With the utilization of metabolomics,...
Introduction Preeclampsia is a heterogeneous gestational disease characterized by maternal hypertens...
Background: To study the effectiveness of choronic villous sampling, followed by molecular analysis,...
Background: Chronic venous disease (CVD) is a prevalent lower limb venous pathology that especially ...
IntroductionPre-eclampsia is a hypertensive gestational disorder that affects approximately 5% of al...
β-thalassemia is one of the most common monogenic disorders and a life-threatening health issue in c...
Introduction Metabolomics identifies phenotypical groups with specific metabolic profiles, being inc...